Table 2.

Surgical Treatment

	All patients (n=257)		Patients with <15 nodes examined (n=129)		Patients with ≥ 15 nodesexamined (n=128)		p – value <15 vs. ≥15 nodes examined
	n or median	% or range	n or median	% or range	n or median	% or range
Resection							0.9929
Distal/subtotal gastrectomy	128	49.8	64	49.6	64	50.0
Proximal /esophagogastrectomy	55	21.4	28	21.7	27	21.1
Total gastrectomy	74	28.8	37	28.7	37	28.9
Reconstruction							1.0000
Billroth I	3	1.2	2	1.6	1	0.8
Billroth II	113	44.0	57	44.2	56	43.8
Esophagogastrostomy	50	19.5	25	19.4	25	19.5
Roux-en-Y	91	35.4	45	34.9	46	35.9
Distal pancreatectomy	14	5.4	6	4.7	8	6.3	0.5962
Splenectomy	31	12.1	14	10.9	17	13.3	0.5715
Other adjacent organs resection	27	10.5	16	12.4	11	8.6	0.4164
Resection margin							0.5896
No gross or microscopic disease	211	82.1	108	83.7	103	80.5
Microscopic disease	43	16.7	19	14.7	24	18.8
Gross disease	3	1.2	2	1.6	1	0.8
30 day mortality	10	3.9	6	4.7	4	3.1	0.5270
Length of stay (days)	9	3–156	9d	3–156	9d	4–109	0.6143
Chemotherapy	104	40.5	45	34.9	59	46.1	0.0758
Radiation therapy	81	31.5	37	28.7	44	34.4	0.3493